What We're Reading
Industry reads hand-picked by our editors
Apr 12, 2021
Apr 09, 2021
-
The New York Times
Kati Kariko Helped Shield the World From the Coronavirus
-
The Boston Globe
MIT scientists launch Future Founders Initiative to help solve biotech’s ‘missing women’ problem
-
Biocentury
CBO report supports biopharma view of value of M&A
-
Barron's
How a Simple Blood Test Could Reduce Cancer Deaths
Apr 08, 2021
-
POLITICO
Senior Trump and Biden officials knew for months about problems at vaccine plant
-
Chemical & Engineering News
Pfizer unveils its oral SARS-CoV-2 inhibitor
-
The Wall Street Journal
Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Days
-
Fierce Biotech
Ventus raises $100M to pursue NRLP3, crack undruggable targets
Apr 07, 2021
-
The New York Times
U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted
-
STAT
Troubling podcast puts JAMA, the ‘voice of medicine,’ under fire for its mishandling of race
-
Vanity Fair
“We Are Hoarding”: Why the U.S. Still Can’t Donate COVID-19 Vaccines to Countries in Need
-
Evaluate Vantage
Biotech venture financing starts the year with a bang
Apr 06, 2021
-
The Wall Street Journal
Covid Arsenal Needs Pills as Well as Shots
-
Chemical & Engineering News
IL-2 treatment can be dangerous. Here’s how drug firms are trying to fix it
-
The New York Times
Researchers Are Hatching a Low-Cost Coronavirus Vaccine
Apr 05, 2021
-
Science
Side effect worry grows for AstraZeneca vaccine
-
The Boston Globe
Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
-
The Wall Street Journal
CEO Transformed Treatment for HIV, Hepatitis
